| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5888906 | Bone | 2016 | 26 Pages |
Abstract
In conclusion, the use of SSRIs seems to accelerate postmenopausal bone loss in a dose-response manner. Associations between TCA and other antidepressant use and bone loss may also exist. Thus, the possibility of increased risk of osteoporosis should be considered when prescribing antidepressants for postmenopausal women.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Päivi H. Rauma, Risto J. Honkanen, Lana J. Williams, Marjo T. Tuppurainen, Heikki P. Kröger, Heli Koivumaa-Honkanen,